| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.2 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.2 |